Longeveron (LGVN) Non-Current Assets (2021 - 2026)

Longeveron (LGVN) recorded quarterly Non-Current Assets of $4.4 million in Q1 2026, down 9.46% quarter-over-quarter from $4.8 million in Q4 2025, and down 21.86% on a YoY basis from $5.6 million in Q1 2025.

Longeveron (LGVN) Non-Current Assets (2021 - 2026) Analysis & Trends

Longeveron's Non-Current Assets history runs 6 years deep, the most recent figure standing at $4.4 million for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 21.86% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $19.9 million (down 15.95% YoY), while the FY2025 annual figure was $4.8 million, down 18.94% from the prior year.
  • Non-Current Assets was $4.4 million for Q1 2026 at Longeveron, down from $4.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $7.1 million in Q4 2022 to a low of $4.4 million in Q1 2026.
  • Historically, Non-Current Assets has averaged $5.9 million across 5 years, with a median of $6.0 million in 2024.
  • The sharpest annual moves came in 2022 and 2026: Non-Current Assets retreated 3.43% in 2022, then dropped 21.86% in 2026.
  • A 5-year view of Non-Current Assets shows it stood at $7.1 million in 2022, then dropped by 12.66% to $6.2 million in 2023, then dropped by 4.75% to $5.9 million in 2024, then dropped by 18.94% to $4.8 million in 2025, then slipped by 9.46% to $4.4 million in 2026.
  • The last three Non-Current Assets figures came in at $4.4 million (Q1 2026), $4.8 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00 4.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.36 Mn
Dec 31, 2025 4.81 Mn
Sep 30, 2025 5.22 Mn
Jun 30, 2025 5.48 Mn
Mar 31, 2025 5.57 Mn
Dec 31, 2024 5.93 Mn
Sep 30, 2024 6.14 Mn
Jun 30, 2024 5.98 Mn
Mar 31, 2024 5.94 Mn
Dec 31, 2023 6.23 Mn
Sep 30, 2023 6.58 Mn
Jun 30, 2023 6.80 Mn
Mar 31, 2023 6.94 Mn
Dec 31, 2022 7.13 Mn
Dec 31, 2021 7.39 Mn